Previous Close | 49.32 |
Open | 48.70 |
Bid | 48.63 x 2900 |
Ask | 48.81 x 4000 |
Day's Range | 48.43 - 49.25 |
52 Week Range | 33.36 - 54.53 |
Volume | 7,451,870 |
Avg. Volume | 8,224,438 |
Market Cap | 42.269B |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.80 |
Earnings Date | Mar 31, 2021 - Apr 05, 2021 |
Forward Dividend & Yield | 1.87 (3.79%) |
Ex-Dividend Date | Nov 18, 2020 |
1y Target Est | 44.83 |
Following President-elect Joe Biden’s COVID-19 Update, Walgreens issued the following statement from John Standley, Walgreens president.
A former Arkansas health official is sounding alarms about the pace of coronavirus vaccines being administered to residents of long-term care facilities under a U.S. plan that puts major pharmacy chains CVS and Walgreens in charge of many of the shots. Fewer than 10% of doses allocated to those Arkansas seniors have been administered, according to the state health department. The two pharmacies are working with about 40% of the state's facilities.
One key to unlocking the logjam of COVID-19 vaccines is in plain view but so far overlooked: the neighborhood retail pharmacy. As of Monday, 9 million people had received at least one dose of the Pfizer (PFE) or Moderna (MRNA) vaccines since they were approved in December. Pfizer’s vaccine must be stored at minus 70 degrees Celsius which complicates inoculation efforts that are not close to specialty freezers.